- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02054975
Vitamin D in Pediatric Asthma: a Randomized Controlled Open-label Pilot Trial (D-Asthma)
Prospective Open Pilot of Low vs. Higher Dose Vitamin D in D-deficient Asthmatic Children: Does Diet Predict Immune Function and Asthma Symptom Response to Vitamin D Supplementation?
This is a pilot randomized controlled trial of lower vs. higher dose vitamin D supplementation in D-deficient asthmatic children, to determine necessary sample sizes for outcome measures in a larger multisite study, and to examine possible relationships and effect sizes between various biological markers that may be important to the pathophysiology of childhood asthma.
Aims of the study are to:
- Evaluate effect sizes for relationships between serum 25OH-vitD and omega-fatty acid (FA) biomarkers, before and after supplementation with lower or higher dose vitamin D, on immune function, and asthma severity.
- Characterize changes in innate and adaptive immune function and inflammatory responses in asthmatic D-deficient youth at baseline and after vitD supplements, by dietary O6:O3FA status and vitD dose.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
An estimated up to 120 youth meeting eligibility criteria will be screened for vitamin D deficiency, and if found deficient, will be offered enrollment in this study.
Eligible children who assent and whose parent/guardian consent to participate will be randomized to low dose vs. higher dose vitamin D to take across a 3-month period of time. Blood, questionnaires, and pulmonary function tests will be obtained at baseline and end of study. Weekly phone calls will check on any questions or concerns the participant or their family may have.
Aims and Hypotheses:
Aim I: Evaluate effect sizes for relationships between omega-FA and vitD biomarkers, pre- and post- low and higher dose vitamin D supplementation, in diet, immune function, and asthma severity.
Aim II: Characterize changes in innate and adaptive immune function and inflammatory responses in asthmatic D-deficient youth at baseline and after vitD supplements, by O6:O3FA status and vitD dose.
Exploratory: Compute effect sizes/odds ratios for differences in pulmonary function, self-reported asthma severity, depressive symptoms, hospitalization/ED visits, and medication changes based on treatment group.
Effect sizes will be calculated for all continuous outcome variables by:
Effect Size (ES) = Average of the post-test scores - Average of the pre-test scores Average standard deviation
Odds ratios for the categorical asthma severity variable will be computed through logistic regression by treatment group with no covariates.
Examine differences in pulmonary function tests, self-reported asthma severity, depressive symptoms, hospitalization/ED visits, and medication changes based on treatment group. Omega fatty acid intake and allergic status will be included as potentially mediating variables.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Nationwide Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1. Informed consent and assent signed and dated before participation.
- 2. Male or female, ages 8 through 17 at baseline; all races and ethnicities
- 3. asthma and currently taking a prescribed daily inhaled steroid asthma medication
- 4. English-speaking with at least one English-speaking parent
- 5. vitamin D deficiency (<20 ng/mL)
- 6. compliant with attending at least 2/4 of their last asthma-related scheduled clinic visits
Exclusion Criteria:
- 1. If female, pregnant, planning to become pregnant, and/or sexually active and not using reliable contraception
- 2. Unable to provide informed consent (mental retardation, etc)
- 3. Current substance dependence (within the past 2 months)
- 4. Known metabolic bone disease, including rickets
- 5. Known malabsorption disease: Crohn's, ulcerative colitis, celiac sprue
- 6. BMI>40
- 7. Has begun new treatment with vitamin D (>600 IU/day) within the past month
- 8. Treatment with prednisone or other oral or IV steroid within the past 4 weeks
- 9. Taking mineral oil or thiazide diuretics on a daily basis
- 10. Acute or chronic liver, renal, endocrine, neurologic, infectious, autoimmune, cardiac, pulmonary, gastrointestinal, hematologic, metabolic disorder or any other disorder, per study physician judgment.
- 11. Severe treatment noncompliance documented in medical record or by managing provider report.
Our definition of a highly effective method of birth control is consistent with ICH Guidance for Industry M3 Nonclinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals (April 1997) when used consistently and correctly, such as implants, injectables, oral contraceptives, some intrauterine devices (IUDs), sexual abstinence, or a vasectomized partner. Subjects will also be reminded to use condoms to prevent sexually transmitted diseases and as a second method toward birth control.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: vitamin D2 + vitamin D3
Vitamin D2 50,000 IU each week x 4 + vitamin D3 4,000 IU each day for 3 months
|
higher dose vitamin D
Other Names:
|
Active Comparator: Vitamin D lower dose
800 IU vitamin D3 by mouth each day for 3 months
|
lower dose vitamin D
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vitamin D levels
Time Frame: change in serum vitamin D level from baseline to 12 weeks
|
Primary: 1. 25-OH vitamin D (D2, D3): 1.0 ml sample sent to Esoterix Laboratory Services (Austin, TX) through NCH and run via high pressure liquid chromatography (HPLC), Tandem Mass Spectrometry analysis. Samples processed individually, not batched, for intervention study purposes. |
change in serum vitamin D level from baseline to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Side Effects Form for Children and Adolescents (SEFCA)
Time Frame: Baseline, end of week 12
|
structured interviewer-administered questionnaire inquiring about body systems health and concerns
|
Baseline, end of week 12
|
Block Kids 2004 Food Frequency Questionnaire
Time Frame: baseline, and end of week 12
|
a questionnaire inquiring how often children eat particular items from different food groups
|
baseline, and end of week 12
|
immune status
Time Frame: baseline, and end of week 12
|
key pro-inflammatory and anti-inflammatory cytokines as well as T-cell ratios will be compared before and after vitamin D supplementation
|
baseline, and end of week 12
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
asthma severity
Time Frame: baseline, and end of week 12
|
via pulmonary function tests
|
baseline, and end of week 12
|
quality of life
Time Frame: Baseline, and end of week 12
|
pediatric quality of life questionnaire, including questions about asthma
|
Baseline, and end of week 12
|
omega fatty acid profile
Time Frame: Baseline, and end of week 12
|
red blood cells will be analyzed for omega fatty acid percentages and ratios of omega 3 fatty acids will be compared to omega 6 fatty acids.
|
Baseline, and end of week 12
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Barbara L Gracious, MD, Nationwide Children's Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Immune System Diseases
- Lung Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Nutrition Disorders
- Avitaminosis
- Deficiency Diseases
- Malnutrition
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity
- Vitamin D Deficiency
- Asthma
- Physiological Effects of Drugs
- Micronutrients
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Vitamin D
- Cholecalciferol
- Vitamins
- Ergocalciferols
Other Study ID Numbers
- IRB13-00504
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
-
Okan UniversityArçelik A.Ş.Completed
-
Brigham and Women's HospitalCompletedVitamin d Deficiency
Clinical Trials on Vitamin D2 + vitamin D3
-
Boston UniversityCompleted
-
Atlanta VA Medical CenterEmory UniversityCompleted
-
University of HelsinkiUniversity College Cork; Technical University of DenmarkCompletedSerum 25-hydroxyvitamin D Concentrations (25OHD)Finland
-
Baltimore VA Medical CenterNational Institute on Aging (NIA); Nutrition Obesity Research Center (NORC)TerminatedMetabolic Syndrome | Vitamin D DeficiencyUnited States
-
Icahn School of Medicine at Mount SinaiCompletedMetabolic Syndrome | Vitamin D Deficiency | PrediabetesUnited States
-
University of California, Los AngelesCompleted
-
Creighton UniversityBTR Group; Health Future FoundationCompleted
-
Shriners Hospitals for ChildrenCompletedBurns | Bone DemineralizationUnited States
-
University of CopenhagenCompleted
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Crohn... and other collaboratorsTerminatedCrohn's Disease | Ulcerative Colitis | Inflammatory Bowel DiseaseUnited States